Key result
Five GPX4 single nucleotide variants were associated with postoperative atrial fibrillation risk (permutated p ≤ 0.05) and eight with altered myocardial GPx4 content and activity (p < 0.05).
Why the study?
Heterogeneity in postoperative atrial fibrillation incidence suggests genetic factors modify risk, leading researchers to examine whether GPX4 single nucleotide variants associate with POAF and altered myocardial GPx4 content or activity.
Do GPX4 single nucleotide variants increase the risk of postoperative atrial fibrillation in patients undergoing elective CABG surgery?
Cohort (n=189)
Do GPX4 single nucleotide variants increase the risk of postoperative atrial fibrillation in patients undergoing elective CABG surgery?
p-value: p=≤ 0.05
Specific GPX4 genetic variants are associated with altered myocardial enzyme activity and an increased risk of postoperative atrial fibrillation following CABG surgery.
GPX4 variants may stratify POAF risk; leaves open whether GPx4 modulation prevents postoperative arrhythmias.
Heterogeneity in the incidence of postoperative atrial fibrillation (POAF) following heart surgery implies that underlying genetic and/or physiological factors impart a higher risk of this complication to certain patients. Glutathione peroxidase-4 (GPx4) is a vital selenoenzyme responsible for neutralizing lipid peroxides, mediators of oxidative stress known to contribute to postoperative arrhythmogenesis. Here, we sought to determine whether GPX4 single nucleotide variants are associated with POAF, and whether any of these variants are linked with altered GPX4 enzyme content or activity in myocardial tissue. Sequencing analysis was performed across the GPX4 coding region within chromosome 19 from a cohort of patients (N = 189) undergoing elective coronary artery bypass graft (−/+ valve) surgery. GPx4 enzyme content and activity were also analyzed in matching samples of atrial myocardium from these patients. Incidence of POAF was 25% in this cohort. Five GPX4 variants were associated with POAF risk (permutated p ≤ 0.05), and eight variants associated with altered myocardial GPx4 content and activity (p < 0.05). One of these variants (rs713041) is a well-known modifier of cardiovascular disease risk. Collectively, these findings suggest GPX4 variants are potential risk modifiers and/or predictors of POAF. Moreover, they illustrate a genotype−phenotype link with this selenoenzyme, which will inform future mechanistic studies.
No takes yet. Share an insight, caveat, or question.
Berdaweel et al. (2022) conducted a cohort in Postoperative atrial fibrillation (n=189). GPX4 single nucleotide variants was evaluated on Postoperative atrial fibrillation (POAF) (p=≤ 0.05). Five GPX4 single nucleotide variants were associated with postoperative atrial fibrillation risk (permutated p ≤ 0.05) and eight with altered myocardial GPx4 content and activity (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: